I. Peeters

Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents

Christoph Königs, Claudio Viscoli, Susanna Esposito, 2012, AIDS.

Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor‐naïve, nonnucleoside reverse transcriptase inhibitor‐experienced patients: study TMC125‐C227 *

K. Ruxrungtham, M. Peeters, J. Vingerhoets, 2008, HIV medicine.

Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor‐naïve, nonnucleoside reverse transcriptase inhibitor‐experienced patients: study TMC125‐C227 *

K. Ruxrungtham, M. Peeters, J. Vingerhoets, 2008, HIV Medicine.